EICHOR
● Completed
Safety and Efficacy Study of Sofpironium Bromide in Subjects With Axillary Hyperhidrosis (BBI-4000-CL-302)
Condition: Axillary Hyperhidrosis · Sponsor: Botanix Pharmaceuticals
About this study
Hyperhidrosis is a disorder of abnormal excessive sweating. Primary hyperhidrosis (armpits, hands, and feet) affects approximately 4.8% of the US population and is believed to be caused by an overactive cholinergic response of the sweat glands. Current therapies have limited effectiveness, significant side effects, and can be invasive and costly. Sofpironium bromide (BBI-4000) is a novel soft-drug in development for the topical treatment of hyperhidrosis. This Phase 3 study will assess the safety and efficacy of sofpironium bromide, 15% gel versus vehicle (2 treatment arms), applied for the treatment of axillary hyperhidrosis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (42)
| Cahaba Dermatology Skin & Health Center | Birmingham, Alabama, United States | — |
| Advanced Research Associates | Glendale, Arizona, United States | — |
| Arkansas Research Trials | North Little Rock, Arkansas, United States | — |
| First OC Dermatology | Fountain Valley, California, United States | — |
| CoDerm Research | Centennial, Colorado, United States | — |
| Colorado Medical Research Center | Denver, Colorado, United States | — |
| CCD Research, PLLC | Cromwell, Connecticut, United States | — |
| The GW Medical Faculty Associates | Washington D.C., District of Columbia, United States | — |
| Driven Research, LLC | Coral Gables, Florida, United States | — |
| Florida Academic Dermatology Centers Research & Education, LLC | Coral Gables, Florida, United States | — |
| GSI Clinical Research | Margate, Florida, United States | — |
| Cordova Research Institute | Miami, Florida, United States | — |
+ 30 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03948646